-1366x0.jpg)
The HASAM 2023 Annual Scientific Conference attracted the attendance of over 300 delegates, including embryology experts, lab directors, clinical doctors, heads of leading Assisted Reproduction centers nationwide, and international assisted reproduction experts. This event provided a platform for delegates to connect, exchange knowledge, learn, and stay updated on clinical and practical aspects of assisted reproduction, including: ovarian stimulation, embryo transfer, infertility treatment based on genetic testing, male infertility solutions, ect.
The main theme of this year's conference was "Updating Outstanding Achievements to Enhance Success Rates in Assisted Reproduction," featuring 26 high-quality scientific reports. A highlight of the conference was the genetics session, co-chaired by Le Thi Lan Phuong, M.Sc., M.D. (Vinmec Hospital) and Pham Dinh Minh, Ph.D. (Director of GENTIS R&D), which included four presentations focusing on embryos, genetics, PGT techniques, andrology testing, etc.
The HASAM 2023 Annual Scientific Conference took place on December 10, 2023.
During the discussion session, the report titled "Sexually Transmitted Diseases and Infertility: Clinical Significance of Testing and Treatment Approaches" by Nguyen Ba Hung, M.Sc., M.D. (Vinmec Hospital) garnered significant attention from attendees. According to Doctor Hung, he highlighted that sexually transmitted diseases (STDs) are complex conditions impacting all stages of male and female reproduction (eggs, sperm, embryos, babies,...). Currently, PCR testing for 12 pathogens is the most prevalent NAAT method for detecting and quantifying STI agents. It is considered the gold standard for clinical diagnosis, boasting a sensitivity and specificity exceeding 98%, and can be performed simultaneously for multiple pathogens.
In his presentation, Doctor Hung also included information about GENTIS's STDs combo test for 12 pathogens, utilizing Realtime PCR technology (Caregene). He expressed high praise for GENTIS's STDs testing, recognizing its ability to optimize diagnosis accuracy for doctors and the costs for patients.
Nguyen Ba Hung, M.Sc., M.D. (Vinmec Hospital) presented a report entitled "Sexually Transmitted Diseases and Infertility: Clinical Significance of Testing and Treatment Approaches."
A highly debated topic at the conference was the report presented by Specialist level 1 Doctor Nguyen Thanh Trung (Hanoi Hospital of Infertility and Andrology) titled "Clinical Outcomes of Mosaic Embryo Transfers at Hanoi Hospital of Infertility and Andrology." This research, which is part of a collaborative scientific project between the hospital and GENTIS, aimed to assess the clinical outcomes of mosaic embryo transfers, specifically focusing on implantation rates, miscarriage rates, and live birth rates. Doctor Trung, who was directly involved in the project, provided valuable insights for clinicians, suggesting that mosaic embryos with less than 50% mosaicism could be considered for patients lacking euploid embryos. He also emphasized the crucial need for thorough risk assessment and comprehensive counseling for patients undergoing mosaic embryo transfer.
Specialist level 1 Doctor Nguyen Thanh Trung (Hanoi Infertility and Andrology Hospital) presented research titled "Clinical Outcomes of Mosaic Embryo Transfers at Hanoi Hospital of Infertility and Andrology."
Especially, GENTIS was particularly proud that Pham Dinh Minh, Ph.D. (Director of GENTIS R&D Center) was invited to chair and present a report titled "Personalized Treatment of Infertility Based on Gene and Genetic Testing: Current Status and Trends." He considered that gene/genetic testing was becoming prevalent in assisted reproduction and obstetrics in Vietnam. In the future, gene/genetic testing will become more personalized to individual patients, aiding in treatment and proactive healthcare management.
Besides, Dr. Minh also shared insights into GENTIS's testing ecosystem for screening, diagnosis, and personalized treatment in assisted reproduction, including:
- Testing for Parents and Embryos:
- Mother: HPV, Thalassemia, Thrombophilia, Advanced Genetic Screening...
- Father: Andrology testing kit, Karyotype; Advanced Genetic Screening for 150 genes...
- Embryo: PGT-A/SR, PGT-M, PGT-One, PGT-Plus, ASEM Test
- Embryo Transfer Environment Testing:
- Genratest: Personalized embryo transfer timing
- PMTest: Uterine lining microbiome identification
- Maternal and Fetal Health Testing:
Preeclampsia, Antiphospholipid syndrome, NIPT-basic/Geneva, Newborn Screening
Pham Dinh Minh, Ph.D. (Director of GENTIS R&D Center) presented a report titled "Personalized Treatment of Infertility Based on Gene and Genetic Testing: Current Status and Trends."
Proudly partnering as a Gold Sponsor of the HASAM 2023 Annual Scientific Conference, GENTIS impressed attendees with its product showcase booth and engaging activities. Many conference participants checked in at the booth to receive a complimentary copy of the book "Male Infertility Through the Lens of Genetics." The event also featured a mini-game with numerous gifts as a token of appreciation for the esteemed doctors in the Conference.
The GENTIS product exhibition booth drew significant attention from numerous attendees with its many engaging activities.
These were some of the highlights of GENTIS's participation in the HASAM 2023 Annual Scientific Conference. Through this year's conference, GENTIS hoped to bring its comprehensive gene testing ecosystem closer to doctors, experts, and healthcare professionals in Vietnam. Congratulations once again on the resounding success of the conference.
